Table 2—

Association between selected patient characteristics and action for patients with HbA1c ≥7%

CharacteristicRate of action Overall (%)Crude OR (95% CI)Strata-specific rates (%)
Adjusted OR (95% CI)
“Consider action” (HbA1c 7–8%) (n = 106)“Recommend action” (HbA1c >8%) (n = 188)
Age
 >65 years (n = 97)60.0*0.45* (0.27–0.76)36.486.00.80 (0.43–1.49)
 <65 years (n = 197)76.637.391.3
Sex
 Male (n = 113)74.31.33 (0.79–2.25)32.492.41.05 (0.55–2.0)
 Female (n = 181)68.538.988.1
Race
 Black (n = 19)47.4*0.34* (0.13–0.88)0*81.80.18* (0.04–0.69)
 Non-black (n = 275)72.439.890.4
Ethnicity
 Hispanic (n = 97)79.4*1.94* (1.09–3.44)34.893.21.29 (0.64–2.58)
 Non-Hispanic (n = 197)66.537.487.7
Insurance
 Medicare only (n = 76) (Medication costs not covered)59.2*0.49* (0.28–0.85)34.380.5*0.59 (0.31–1.14)
 All other (n = 218)74.838.092.5
Glycemic medications
 2 or more (n = 168)73.81.41 (0.85–2.34)40.090.31.24 (0.67–2.28)
 0 to 1 (n = 126)66.733.389.3
3 or more chronic comorbidities
 Yes (n = 190)68.40.72 (0.42–1.24)34.291.20.95 (0.50–1.81)
 No (n = 104)75.043.387.8
  • *

    * P < 0.05;

  • P = 0.10. P values determined for crude associations, strata-specific associations, and stratified analysis (Mantel-Hantzel).